Overview * Sweden life science supplier's Q2 net sales rose 6% yr/yr, beating analyst expectations * Q2 EBITA up 11% and margin improved to 12.6% * Company says recent acquisitions contributed to
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Irish factory activity robust in August as new business surges, PMI shows
DUBLIN, Sept 1 (Reuters) - Ireland's manufacturing sector expanded robustly again in August and at…
California, Writers Guild ask court to reject Paramount request for $1.88 billion bond
By Dawn Chmielewski LOS ANGELES, Aug 31 (Reuters) - The State of California and 11…
Brazil issues new rules on ticket sales for cultural events
SAO PAULO, Aug 31 (Reuters) - Brazil's government issued on Monday new regulations governing ticket…
